In a recent interview, Gadi Lalazar, MD, discussed new research demonstrating the capability of natural language processing (NLP) to enhance recognition of incidental hepatic steatosis in ultrasound reports.
|Articles|December 14, 1994
Du Pont's Neurolite approved by FDA
Du Pont Merck Pharmaceuticalreceived approval last month from the Food and Drug Administrationfor Neurolite, a technetium-tagged brain SPECT imaging agent.Neurolite becomes the second brain SPECT agent on the market,joining Amersham's Ceretec, also a
Advertisement
Du Pont Merck Pharmaceuticalreceived approval last month from the Food and Drug Administrationfor Neurolite, a technetium-tagged brain SPECT imaging agent.Neurolite becomes the second brain SPECT agent on the market,joining Amersham's Ceretec, also a technetium-labeled agent. DuPont Merck, of North Billerica, MA, plans to begin shipping Neurolitein January. The product is indicated for brain perfusion studiesin stroke patients (SCAN 9/14/94).
Advertisement
Related to this article
Report One, reportedly the first agentic reporting tool specifically geared to breast imaging, is one of three new products that will be showcased by MagView at the upcoming RSNA conference.
Artificial intelligence plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume, according to a new study to be presented at the American Heart Association Scientific Sessions 2026 this week.
While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.
While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.
The Evident Vascular Guidance System and Evident peripheral imaging catheters reportedly offer enhanced image clarity and workflow efficiencies for intravascular ultrasound.
Amid the burgeoning imaging volumes and ongoing radiologist shortage, this author suggests that more active involvement by radiologists in the creation and development of AI models could go a long way.
In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the evolution, research and pearls for ablation procedures, and emerging considerations for histotripsy in the realm of interventional oncology.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Study Shows Benefits of AI Analysis for Ultrasound Reports and Incidental Findings of Hepatic Steatosis
2
Next-Generation Breast Imaging Platform to be Unveiled at RSNA
3
Addressing Radiology’s Workforce Crisis: Can a Shift from Being Passive AI Users to Active AI Creators Have an Impact?
4
CCTA Study: AI-Powered Plaque Analysis Reveals Coronary Plaque in 87 Percent of Retired NFL Players
5